Verismo Therapeutics: Funding, Investors & Team (Oct 2026)
Verismo Therapeutics creates new chimeric antigen receptors (CARs) that improve T-cell-based immunotherapy for cancer. Their therapy, KIR-CAR, aims to stimulate T cells naturally without causing exhaustion, specifically for treating solid tumors like pancreatic cancer, mesothelioma, and ovarian cancer.
Verismo Therapeutics has raised $49.3M across 4 funding rounds on record, the most recent an undisclosed round of $28.0M announced in Apr 2026.
That round is above the $8.4M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Verismo Therapeutics Company Profile and Key Stats
Latest funding round on record: Apr 2026.
Verismo Therapeutics Funding Rounds
Verismo Therapeutics raised $17.0M in a Seed announced in Jul 2023.
1.2 years later, an undisclosed round of $150k was announced in Sep 2024.
4 months later, a Seed of $4.1M was announced in Jan 2025.
1.3 years later, an undisclosed round of $28.0M was announced in Apr 2026.
Verismo Therapeutics Founders and Leadership Team
Contact details for the Verismo Therapeutics team: 1 of 2 have an email address on file.
Start 14-day free trial →Verismo Therapeutics Funding Compared to Other Biotechnology Startups
Verismo Therapeutics' latest round of $28.0M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Verismo Therapeutics in Biotechnology and Philadelphia
Companies Similar to Verismo Therapeutics
Prolific Machines is a biotech company located in San Francisco, California, that was established in 2020. It…
Altay Therapeutics is a biotech company focused on finding and discovering small molecule therapies for…
Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…
Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…
Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…
Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…
Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.
Serán is a contract development and manufacturing organization providing a comprehensive suite of…
Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…
Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…
Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…
Verismo Therapeutics Funding FAQs
What does Verismo Therapeutics do?
Verismo Therapeutics creates new chimeric antigen receptors (CARs) that improve T-cell-based immunotherapy for cancer. Their therapy, KIR-CAR, aims to stimulate T cells naturally without causing exhaustion, specifically for treating solid tumors like pancreatic cancer, mesothelioma, and ovarian cancer.
How much funding has Verismo Therapeutics raised?
Verismo Therapeutics has raised $49.3M across 4 rounds on record. The most recent is an undisclosed round of $28.0M announced in Apr 2026.
When did Verismo Therapeutics last raise funding?
Verismo Therapeutics' most recent funding round on record is an undisclosed round of $28.0M, announced in Apr 2026.
Who founded Verismo Therapeutics?
FundedIQ lists Bryan Kim (Founder), Donald L Siegel (Founder) at Verismo Therapeutics.
Where is Verismo Therapeutics headquartered?
Verismo Therapeutics is based in Philadelphia, Pennsylvania, United States.
How many employees does Verismo Therapeutics have?
Verismo Therapeutics is in the 11-50 employee band.
How does Verismo Therapeutics' funding compare to other Biotechnology startups?
Verismo Therapeutics' latest round of $28.0M is above the $8.4M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.
About FundedIQ's Verismo Therapeutics Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Verismo Therapeutics is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.